Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Adcendo ApS (Denmark)
Homepage:
adcendo.com
Alternate names:
Adcendo,
Adcendo ApS
ROR:
00q4xm751
OpenAlex ID:
I4405282944
Works
7
Awards
1
Promoter sequence and architecture determine expression variability and confer robustness to genetic variants
2022
·
Hjörleifur Einarsson
, Marco Salvatore
, et al.
·
eLife
·
55
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
2023
·
Niels Böhnke
, Bård Indrevoll
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
19
PDF
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target
2021
·
Pınar Çakılkaya
, Rikke Raagaard Sørensen
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
The Recycling Collagen Receptor uPARAP Is a Unique Mediator of Stromal Drug Delivery to Carcinoma Cells
2025
·
Kirstine S. Nørregaard
, Ida M.E. Larsen
, et al.
·
Molecular Cancer Therapeutics
·
6
PR072/#1519 Effort: clinical and molecular features associated with clinical benefit from adavosertib with or without olaparib in recurrent ovarian cancer following progression on PARP inhibition (NCT03579316)
2023
·
Naomi Adjei
, Robert Coleman
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies
2026
·
Chao-Chi Wang
, Pernille Barkholt
, et al.
·
Translational Oncology
2743TiP First-in-human (FIH) phase I/II study of ADCE-D01, a urokinase plasminogen activator receptor-associated protein (uPARAP)-targeted antibody-drug conjugate (ADC) carrying a topoisomerase 1 inhibitor payload, in patients with metastatic and/or unresectable soft tissue sarcoma (STS)
2025
·
P. Schoeffski
, S. Bauer
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
7
Citation count:
92
Year
Topic
Type